阻断 ангиотензинII受体类型1 取消了对炼的红素反应
Meihan Guo1,2, David Montero2,3,4
1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Function (Oxford, England)
|July 21, 2025
概括
通常处方的抗高血压药物瓦尔萨坦阻断了运动诱导的红素蛋白 (EPO) 的增加,这是一种对有氧能力至关重要的激素. 这种药物可能通过抑制关键内分泌反应来限制有益的运动适应.
科学领域:
- 运动生理学 运动生理学
- 内分泌学 在内分泌学.
- 心血管药理学心血管药理学
背景情况:
- 运动适应依赖于功能性的内分泌系统.
- 红素 (EPO) 对于通过运动增强有氧能力至关重要.
- 抗高血压药物对运动诱导的EPO产生的影响尚不清楚.
研究的目的:
- 为了调查瓦尔萨坦,一种血管素II型1受体阻断剂 (AT1阻断剂),是否抑制运动诱导的红素 (EPO) 生产.
- 为了确定AT1阻断对EPO调节激素和运动期间心血管参数的影响.
主要方法:
- 随机,双盲,安慰剂控制的交叉研究.
- 在中度骑自行车运动之前,63名健康成年人接受了瓦尔萨坦或安慰剂.
- 血液样本测量了EPO,EPO调节激素和血压;评估了心脏功能和VO2峰值.
主要成果:
- 在运动期间,AT1阻塞降低了心脏体积和动脉血压.
- 瓦尔萨坦消除了运动引起的循环EPO增加,特别是在运动后.
- 血管新素II和阿尔多斯激素对运动的荷尔蒙反应被AT1阻断削弱.
结论:
- 在男性和女性中,AT1阻断显著抑制了对运动的急性 erythropoietin (EPO) 反应.
- 针对AT1信号的抗高血压药物可能会阻碍与运动相关的关键内分泌适应.
- 这一发现表明,对接受AT1阻断剂治疗的个体来说,运动的益处存在潜在的限制.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
910
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
910
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:25Antihypertensive Drugs: Direct Renin Inhibitors
817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
869
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
869
01:24Factors Affecting Erythropoiesis
3.6K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.6K